CompletedNot Applicable

Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma

China79 participantsStarted 2023-11-07

Plain-language summary

This is a retrospective study, including 79 patients with duodenal papillary adenoma, who treated with Endoscopic Papillectomy (EP) at Beijing friendship hospital. The cohort included patients who underwent EP with or without Pancreatic Duct (PD) and Common Bile Duct (CBD) stent placement. The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years. * Identification of duodenal papillary lesions via gastroscopy or duodenoscopy. * Intraductal involvement \<20mm. * Absence of preoperative peripheral lymph node metastasis and pancreatic/biliary duct stenosis (verified by CT, MRI, or other imaging). * Postoperative biopsy confirming adenoma. Exclusion Criteria: * Diagnosis of familial adenomatous polyposis or multiple hamartoma syndrome. * Patients undergoing pancreaticoduodenectomy within a month post-EP for residual lesions.

What they're measuring

Rate of complications

Timeframe: through study completion, an average of 1 year

Rate of complete resection

Timeframe: 1 week after the operation

Trial details

NCT IDNCT06301048

SponsorBeijing Friendship Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-07

View on ClinicalTrials.gov More Duodenal Adenoma trials